In an exclusive interview as part of Inc42’s Moneyball series, founder Yash Kela gives us insights into Singularity’s ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US counterparts.